Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Obstetricia y Ginecología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized Open-Label Study to Compare the Pharmacokinetics, Efficacy, and Safety of Subcutaneous (SC) Trastuzumab With Intravenous (IV) Trastuzumab Administered in Women With HER2-Positive Early Breast Cancer (EBC)
INTERVENTIONAL
Inicio: 16 de oct de 2009
ID: NCT00950300
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01104584
Retirado
Fase 4
ClinicalTrials.gov
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
INTERVENTIONAL
Inicio: 16 de sept de 2019
ID: NCT03988114
Completado
Fase 2
ClinicalTrials.gov
Study of Two Doses of ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer
INTERVENTIONAL
Inicio: 1 de may de 2003
ID: NCT00065533
Completado
Fase 3
ClinicalTrials.gov
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
INTERVENTIONAL
Inicio: 1 de mar de 2004
ID: NCT00171314
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase II Trial Evaluating the Safety and Efficacy of Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer That Have Evidence of Disease Progression on or After Prior Endocrine Therapy
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01528345
Completado
Fase 3
ClinicalTrials.gov
Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia-Folic Acid Clinical Trial (FACT)
INTERVENTIONAL
Inicio: 1 de abr de 2011
ID: NCT01355159
Completado
Fase 2
ClinicalTrials.gov
A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
INTERVENTIONAL
Inicio: 1 de jul de 2005
ID: NCT00489359
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumors Express PD-L1
INTERVENTIONAL
Inicio: 25 de jul de 2022
ID: NCT05382286
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Multicenter Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) vs. Exemestane (AROMASIN™) in Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer With Disease Progression After Prior Non-Steroidal Aromatase Inhibitor (AI) Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2003
ID: NCT00065325
Completado
ClinicalTrials.gov
A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay
INTERVENTIONAL
Inicio: 1 de oct de 2011
ID: NCT01852617
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Multicentre Trial Comparing the Efficacy and Tolerability of 250mg of Faslodex (Long Acting ICI 182,780) With 20mg of Nolvadex (Tamoxifen) in Postmenopausal Women With Advanced Breast Cancer
INTERVENTIONAL
Inicio: 1 de nov de 1998
ID: NCT00241449
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant in Combination With Phesgo Versus Phesgo After Induction Therapy With Phesgo + Taxane in Patients With Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally-Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 18 de jul de 2022
ID: NCT05296798
Por invitación
ClinicalTrials.gov
Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
OBSERVATIONAL
Inicio: 1 de ago de 2024
ID: NCT06447532
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double Blind, Placebo-controlled Trial Comparing Capecitabine Plus Sorafenib Versus Capecitabine Plus Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
INTERVENTIONAL
Inicio: 21 de feb de 2011
ID: NCT01234337
Terminado
Fase 4
ClinicalTrials.gov
Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02342002
Completado
ClinicalTrials.gov
Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study
OBSERVATIONAL
Inicio: 27 de dic de 2016
ID: NCT02984423
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01067976
Completado
Fase 3
ClinicalTrials.gov
A Randomized, 3 Arm, Multicenter, Phase III Study to Evaluate the Efficacy and the Safety of T-DM1 Combined With Pertuzumab or T-DM1 Combined With Pertuzumab-Placebo (Blinded for Pertuzumab), Versus the Combination of Trastuzumab Plus Taxane, as First Line Treatment in HER2 Positive Progressive or Recurrent Locally Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 31 de jul de 2010
ID: NCT01120184
Completado
ClinicalTrials.gov
Additional Effect of Pain Neuroscience Education, Motor Imagery and Action Observation in Patients With Chronic Temporomandibular Disorders. A Randomized Controlled Trial
INTERVENTIONAL
Inicio: 31 de ago de 2021
ID: NCT05003349
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros